Ls Investment Advisors, LLC Neurocrine Biosciences Inc Transaction History

Ls Investment Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$89.43 - $102.27 $258,452 - $295,560	-2,890 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$87.57 - $119.4 $253,077 - $345,066	2,890 New	2,890 $281,000
Q2 2020 Aug 10, 2020	SELL	$85.09 - $130.36 $8,168 - $12,514	-96 Closed	0 $0
Q1 2020 Apr 20, 2020	SELL	$75.11 - $113.76 $47,694 - $72,237	-635 Reduced 86.87%	96 $8,000
Q4 2019 Jan 31, 2020	BUY	$86.8 - $118.57 $63,450 - $86,674	731 New	731 $79,000

627

94.3M

632K

621K

Ticker NBIX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 95,639,296
Market Cap $12.1B
Description
Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Ls Investment Advisors, LLC with notifications on news.